| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.4 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.4 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |